BROWNSTEIN HYATT FARBER SCHRECK, LLP

Lobbying for ST SHARED SERVICES LLC DBA KEENOVA THERAPEUTICS · Pharmaceutical company

Filing 2nd Quarter - Report

Reporting period

2nd Quarter 2026

Apr 1 - June 30 · Posted Jul 16, 2026

Income

$80,000.00

What the client paid this registrant for the period.

Client based in

District of Columbia

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 2

Trade (domestic/foreign)

Companys expansion of its domestic footprint.

Pharmacy

Issues related to pharmaceutical manufacturing Tax and trade policy affecting the pharmaceutical industry

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.